Daniel L. Van Dyke, Ph.D., FACMG
Project Involvement: Tissue Core/Cytogenetics
Dr. Van Dyke's research interests include cytogenetic studies in hematologic diseases, especially Chronic Lymphocytic Leukemia, and the clinical significance of constitutional chromosome abnormalities, especially sex chromosome abnormalities, balanced chromosome rearrangements, and small marker chromosomes. The CLL studies are collaborative efforts with Mayo Clinic hematologists and pathologists, and with the CLL Clinical Research Consortium. Current and recent projects include the clinical significance of recurrent chromosome abnormalities in CLL and correlation of these abnormalities with other clinical parameters. The CLL studies also include evaluation of CpG oligonucleotide as a CLL-specific mitogen.
EDUCATION
Fellowship – Molecular Genetics
Henry Ford Health System
Ph.D. – Genetics
Indiana University, Indianapolis
M.S. – Biology
Northern Illinois University
B.S. – Biology
Northern Illinois University